Skip to main content
Heidelberg Pharma AG logo

Heidelberg Pharma AG — Investor Relations & Filings

Ticker · HPHA ISIN · DE000A11QVV0 LEI · 391200E09XYBYITR1W32 F Manufacturing
Open in API
Filings indexed 806 across all filing types
Latest filing 2022-06-22 Report Publication Anno…
Country DE Germany
Listing F HPHA

About Heidelberg Pharma AG

https://heidelberg-pharma.com/en/

Heidelberg Pharma AG is a clinical-stage biopharmaceutical company specializing in the development of targeted cancer therapies. The company's core focus is its proprietary Antibody-Drug Conjugate (ADC) technology platform, which utilizes the toxin Amanitin. This platform, known as Antibody Targeted Amanitin Conjugates (ATACs®), is designed to deliver the highly potent Amanitin payload directly to tumor cells. Heidelberg Pharma is the first company to advance Amanitin into clinical development for cancer treatment. Its lead candidate, HDP-101, is in clinical trials for patients with multiple myeloma. The company leverages its ADC expertise to create novel medicines for oncology.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2022
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports..." and explicitly states that it is announcing *when* and *where* the 'Financial report of the group (half-year/Q2)' will be disclosed (July 12, 2022). The document itself is very short (2026 characters) and serves only to notify the public about the future release of a report, rather than containing the report's content. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement about the publication of a report should be classified as a Report Publication Announcement (RPA). The specific report being announced is a half-year report, but this document is the announcement, not the report itself.
2022-06-22 English
Hinweis auf Halbjahresfinanzbericht vom 01.12.2021 bis zum 31.05.2022
Report Publication Announcement Classification · 100% confidence The document is a short notification (815 characters) announcing the availability of a half-year financial report. It provides a link to the report and specifies the publication date, fitting the 'Menu vs Meal' rule where an announcement of a report is classified as a Report Publication Announcement (RPA) rather than the report itself.
2022-06-22 German
Hinweis auf Halbjahresfinanzbericht vom 01.12.2021 bis zum 31.05.2022
Report Publication Announcement Classification · 99% confidence The document is very short (824 characters) and explicitly states that a 'Finanzbericht' (Financial Report) for the period 01.12.2021 to 31.05.2022 is available on the internet, with a publication date of 12.07.2022. This structure—announcing the availability of a report rather than containing the full report content—fits the definition of a Report Publication Announcement (RPA). Although it concerns a half-year report (which might suggest 'IR' - Interim Report), the document itself is merely the notice of publication, triggering the 'MENU VS MEAL' rule to select RPA.
2022-06-22 German
Heidelberg Pharma AG: Bekanntmachung der Einberufung zur Hauptversammlung am 22.06.2022 in Ladenburg mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 98% confidence The document is titled 'Bekanntmachung der Einberufung zur Hauptversammlung' (Announcement of the Convocation to the General Meeting) and explicitly invites shareholders to the 'ordentlichen virtuellen Hauptversammlung der Heidelberg Pharma AG' (Ordinary Virtual General Meeting of Heidelberg Pharma AG) scheduled for June 28, 2022. The text details the agenda (Tagesordnung), which includes voting on the approval of financial statements, discharge of management/supervisory boards, auditor appointment, and changes to the articles of association related to board size and authorized capital, all typical items for an Annual General Meeting (AGM). Although it is an announcement of the meeting, the content is the full, detailed invitation and agenda, which strongly aligns with the materials presented or distributed in connection with an AGM. Since the primary purpose is the formal convocation and detailing of the AGM agenda, 'AGM Information' (AGM-R) is the most appropriate classification, rather than the fallback 'RPA' or 'RNS', as it contains the core substance of the meeting's purpose and structure.
2022-05-17 German
Heidelberg Pharma AG and Partner Huadong Receive all Approvals for the Announced Transaction from the Authorities and Plan Capital Measure
M&A Activity Classification · 99% confidence The document is an 'Ad hoc announcement – Inside information pursuant to Article 17 MAR' dated May 9, 2022. The core content details the fulfillment of closing conditions for a strategic partnership and, crucially, announces plans for a 'rights issue in cash based on a prospectus of up to EUR 80 million' and the subsequent capital measure. This directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it mentions a prospectus, the primary focus is the capital measure itself, not just the announcement of a report (RPA) or a general regulatory filing (RNS).
2022-05-09 English
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2022
Earnings Release Classification · 100% confidence The document is explicitly titled 'Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2022' and reports on financial figures for the period '1 December 2021 – 28 February 2022'. This content structure—a comprehensive report covering a period shorter than a full fiscal year (Q1 2022) with detailed operational and financial results (sales revenue, operating expenses, net loss, balance sheet)—is characteristic of an Interim Report. The document is the report itself, not merely an announcement of its publication. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2022
2022-04-28 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.